Logo image of IRMD

IRADIMED CORP (IRMD) Stock Analyst Earnings Estimates

NASDAQ:IRMD - Nasdaq - US46266A1097 - Common Stock - Currency: USD

62.67  +1.44 (+2.35%)

After market: 62.67 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
IRMD revenue by date.IRMD revenue by date.
41.81M
31.81%
53.3M
27.48%
65.562M
23.01%
74.481M
13.60%
82.268M
10.46%
100.96M
22.72%
EBITDA
YoY % growth
IRMD ebitda by date.IRMD ebitda by date.
11.23M
1,836.21%
16.3M
45.15%
20.801M
27.61%
22.593M
8.62%
N/AN/A
EBIT
YoY % growth
IRMD ebit by date.IRMD ebit by date.
9.82M
1,392.11%
15.63M
59.16%
20.035M
28.19%
23.652M
18.05%
25.563M
8.08%
35.765M
39.91%
Operating Margin
IRMD operating margin by date.IRMD operating margin by date.
23.49%29.32%30.56%31.76%31.07%35.42%
EPS
YoY % growth
IRMD eps by date.IRMD eps by date.
0.83
102.44%
1.09
31.33%
1.48
35.78%
1.69
14.41%
1.79
5.42%
2.19
22.86%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
0.45
15.08%
0.42
16.17%
0.44
5.64%
0.46
6.74%
0.46
3.41%
Revenue
Q2Q % growth
19.527M
11.89%
19.515M
10.89%
20.406M
13.82%
20.965M
14.40%
21.382M
9.50%
EBITDA
Q2Q % growth
6.497M
9.65%
N/AN/AN/AN/A
EBIT
Q2Q % growth
6.485M
25.68%
5.946M
25.22%
6.382M
13.42%
6.533M
12.85%
6.7M
3.32%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.43 0.390.049.50%
Q2 2024
Q2Q % growth
0.42
16.67%
0.370.0512.81%
Q1 2024
Q2Q % growth
0.36
20.00%
0.340.025.36%
Q4 2023
Q2Q % growth
0.39
21.88%
0.40-0.01-3.61%
Q3 2023
Q2Q % growth
0.43
48.28%
0.370.0616.03%
Q2 2023
Q2Q % growth
0.36
38.46%
0.320.0413.85%
Q1 2023
Q2Q % growth
0.30
36.36%
0.290.013.81%
Q4 2022
Q2Q % growth
0.32
-3.03%
0.310.014.58%
Q3 2022
Q2Q % growth
0.29
26.09%
0.250.0416.05%
Q2 2022
Q2Q % growth
0.26
85.71%
0.240.028.47%
Q1 2022
Q2Q % growth
0.22
69.23%
0.210.015.21%
Q4 2021
Q2Q % growth
0.33
371.43%
0.210.1254.06%
Q3 2021
Q2Q % growth
0.23
109.09%
0.170.0632.64%
Q2 2021
Q2Q % growth
0.14
180.00%
0.100.0444.48%
Q1 2021
Q2Q % growth
0.13
-27.78%
0.100.0327.45%
Q4 2020
Q2Q % growth
0.07
-76.67%
0.11-0.04-34.64%
Q3 2020
Q2Q % growth
0.11
-52.17%
0.100.017.84%
Q2 2020
Q2Q % growth
0.05
-75.00%
-0.010.061,080.39%
Q1 2020
Q2Q % growth
0.18
38.46%
0.150.0317.65%
Q4 2019
Q2Q % growth
0.30 0.210.0943.47%
Q3 2019
Q2Q % growth
0.23 0.160.0745.48%
Q2 2019
Q2Q % growth
0.20 0.150.0530.72%
Q1 2019
Q2Q % growth
0.13 0.15-0.02-15.03%
IRMD Yearly EPS VS EstimatesIRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
18.326M
11.03%
18.459M-133.04K-0.72%
Q2 2024
Q2Q % growth
17.928M
11.15%
18.002M-74K-0.41%
Q1 2024
Q2Q % growth
17.598M
13.72%
17.473M125.12K0.72%
Q4 2023
Q2Q % growth
17.452M
17.44%
17.678M-225.82K-1.28%
Q3 2023
Q2Q % growth
16.505M
23.08%
16.499M6K0.04%
Q2 2023
Q2Q % growth
16.13M
26.81%
15.963M167K1.05%
Q1 2023
Q2Q % growth
15.475M
25.71%
15.062M413.08K2.74%
Q4 2022
Q2Q % growth
14.86M
25.19%
15.166M-306K-2.02%
Q3 2022
Q2Q % growth
13.41M
22.91%
13.45M-40K-0.30%
Q2 2022
Q2Q % growth
12.72M
29.66%
12.853M-133K-1.03%
Q1 2022
Q2Q % growth
12.31M
33.51%
12.45M-140K-1.12%
Q4 2021
Q2Q % growth
11.87M
38.83%
11.864M6K0.05%
Q3 2021
Q2Q % growth
10.91M
41.69%
10.608M302K2.85%
Q2 2021
Q2Q % growth
9.81M
44.48%
8.628M1.182M13.70%
Q1 2021
Q2Q % growth
9.22M
6.22%
8.733M487K5.58%
Q4 2020
Q2Q % growth
8.55M
-21.49%
8.608M-58K-0.67%
Q3 2020
Q2Q % growth
7.7M
-22.69%
8.375M-675K-8.06%
Q2 2020
Q2Q % growth
6.79M
-26.44%
6.569M221K3.36%
Q1 2020
Q2Q % growth
8.68M
2.84%
9.853M-1.173M-11.91%
Q4 2019
Q2Q % growth
10.89M 11.138M-248K-2.23%
Q3 2019
Q2Q % growth
9.96M 9.981M-21K-0.21%
Q2 2019
Q2Q % growth
9.23M 9.086M144K1.58%
Q1 2019
Q2Q % growth
8.44M 8.607M-167K-1.94%
IRMD Yearly Revenue VS EstimatesIRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.15% 3.53% 0.3% 6.07%
Revenue1.06% -2.32% 0.27% 0.55%